A Whole-Blood Four-Gene Panel Distinguishes Pediatric Crohn's Disease from Disorders of Gut-Brain Interaction
In the authors' words
Background and Aims: Crohn's disease and disorders of gut-brain interaction present with overlapping symptoms, and distinguishing them often requires endoscopy. We assessed whether the whole-blood transcriptome at presentation distinguishes these conditions and reflects disease activity. Methods: In a prospective two-center cohort, whole-blood RNA sequencing was performed in 425 treatment-naive participants aged 5 to 25 years (112 Crohn's disease, 313 disorders of gut-brain interaction). Differential expression was modeled for diagnosis and, within Crohn's disease, for the Pediatric Crohn's Disease Activity Index. Co-expression modules were integrated with protein-protein interaction networks, and machine learning distilled network genes into a diagnostic panel, evaluated internally and in an independent pediatric cohort. Results: Of 1,095 diagnosis-associated genes, 377 were also associated with disease activity, all with concordant direction. Five co-expression networks were perturbed, spanning neutrophil degranulation, hemostasis, interferon signaling, and T-cell and cytotoxic lymphocyte programs. A 4-gene panel (PSTPIP2, CLIC4, CACNB4, GZMK) drawn from 4 networks achieved an area under the receiver operating characteristic curve of up to 0.96 in held-out samples and up to 0.93 externally, with external specificity and positive predictive value of up to 0.95 and 0.93, respectively. The panel matched or exceeded every single-network panel with fewer genes, and minimally active Crohn's disease overlapped transcriptionally with disorders of gut-brain interaction. Conclusions: At diagnosis, Crohn's disease is distinguished from disorders of gut-brain interaction by a systemic signature of neutrophil and platelet activation and lymphocyte depletion that scales with disease activity. A 4-gene whole-blood panel may help prioritize symptomatic children for endoscopy and warrants prospective validation.
Appeared: Thursday, November 19. medRxiv. Preprint, not yet peer-reviewed.